NCT03848234View on ClinicalTrials.gov

Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

December 4, 2015

Primary Completion Date

July 29, 2016

Study Completion Date

July 29, 2016

Conditions
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Interventions
DRUG

Estradiol

2 trans dermal patches to be changed twice a week for the duration of 8 weeks.

DEVICE

Placebo

2 trans dermal patches to be changed twice a week for the duration of 8 weeks.

Trial Locations (1)

2011

Clinical Psychiatric Hospital, Codru

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Tangent Data

OTHER

NCT03848234 - Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder | Biotech Hunter | Biotech Hunter